Asthma Severity and Patient-Reported Outcomes in Patients With Asthma and Allergic Rhinitis Initiating Dupilumab in RAPID

Giselle S.  Mosnaim; Njira Lugogo; David Price; Andréanne Côté; Xavier  Muñoz; Vicente  Plaza; Changming  Xia; Hashem  Awad; Jason H.  Kwah

Asthma Severity and Patient-Reported Outcomes in Patients With Asthma and Allergic Rhinitis Initiating Dupilumab in RAPID

Giselle S. Mosnaim, Njira Lugogo, David Price, Andréanne Côté, Xavier Muñoz, Vicente Plaza, Changming Xia, Hashem Awad, Jason H. Kwah

Research output: Contribution to conference › Abstract › peer-review

Abstract

BACKGROUND: Allergic rhinitis (AR) often coexists with asthma and is associated with increased asthma severity. The RAPID global registry enrolled asthma patients initiating dupilumab in real-world practice. This analysis assessed asthma severity and patient-reported outcomes with and without coexisting AR after 12 months in RAPID...

Original language	English
Publication status	Accepted/In press - 10 Apr 2025
Event	EAACI Congress 2025: Breaking boundaries in Allergy, Asthma, and Clinical Immunology - Glasgow, United Kingdom Duration: 13 Jun 2025 → 16 Jun 2025 https://eaaci.org/events_congress/eaaci-congress-2025/

Conference

Conference	EAACI Congress 2025
Country/Territory	United Kingdom
City	Glasgow
Period	13/06/25 → 16/06/25
Internet address	https://eaaci.org/events_congress/eaaci-congress-2025/

Cite this

@conference{83929c93b0b644b98b3f80b96fcb612c,

title = "Asthma Severity and Patient-Reported Outcomes in Patients With Asthma and Allergic Rhinitis Initiating Dupilumab in RAPID",

abstract = "BACKGROUND: Allergic rhinitis (AR) often coexists with asthma and is associated with increased asthma severity. The RAPID global registry enrolled asthma patients initiating dupilumab in real-world practice. This analysis assessed asthma severity and patient-reported outcomes with and without coexisting AR after 12 months in RAPID...",

author = "Mosnaim, {Giselle S.} and Njira Lugogo and David Price and Andr{\'e}anne C{\^o}t{\'e} and Xavier Mu{\~n}oz and Vicente Plaza and Changming Xia and Hashem Awad and Kwah, {Jason H.}",

year = "2025",

month = apr,

day = "10",

language = "English",

note = "EAACI Congress 2025 : Breaking boundaries in Allergy, Asthma, and Clinical Immunology ; Conference date: 13-06-2025 Through 16-06-2025",

url = "https://eaaci.org/events_congress/eaaci-congress-2025/",

}

TY - CONF

T1 - Asthma Severity and Patient-Reported Outcomes in Patients With Asthma and Allergic Rhinitis Initiating Dupilumab in RAPID

AU - Mosnaim, Giselle S.

AU - Lugogo, Njira

AU - Price, David

AU - Côté, Andréanne

AU - Muñoz, Xavier

AU - Plaza, Vicente

AU - Xia, Changming

AU - Awad, Hashem

AU - Kwah, Jason H.

PY - 2025/4/10

Y1 - 2025/4/10

N2 - BACKGROUND: Allergic rhinitis (AR) often coexists with asthma and is associated with increased asthma severity. The RAPID global registry enrolled asthma patients initiating dupilumab in real-world practice. This analysis assessed asthma severity and patient-reported outcomes with and without coexisting AR after 12 months in RAPID...

AB - BACKGROUND: Allergic rhinitis (AR) often coexists with asthma and is associated with increased asthma severity. The RAPID global registry enrolled asthma patients initiating dupilumab in real-world practice. This analysis assessed asthma severity and patient-reported outcomes with and without coexisting AR after 12 months in RAPID...

M3 - Abstract

T2 - EAACI Congress 2025

Y2 - 13 June 2025 through 16 June 2025

ER -

Asthma Severity and Patient-Reported Outcomes in Patients With Asthma and Allergic Rhinitis Initiating Dupilumab in RAPID

Abstract

Conference

Fingerprint

Cite this